United States Metered Dose Inhaler Devices Market Outlook to 2023

United States Metered Dose Inhaler Devices Market Outlook to 2023


  • Products Id :- GDMECC2509DB
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

United States Metered Dose Inhaler Devices Market Outlook to 2023

Summary

GlobalData's new report, "United States Metered Dose Inhaler Devices Market Outlook to 2023", provides key market data on the United States Metered Dose Inhaler Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) for Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market segments.

Global corporate-level profiles of key companies operating within the United States Metered Dose Inhaler Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH.

Reasons to buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Metered Dose Inhaler Devices Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 5

3 Metered Dose Inhaler Devices Market, United States 6

3.1 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2009-2016 6

3.2 Metered Dose Inhaler Devices Market, United States, Revenue ($m), 2016-2023 7

3.3 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2009-2016 8

3.4 Metered Dose Inhaler Devices Market, United States, Volume (Units), 2016-2023 9

3.5 Metered Dose Inhaler Devices Market, United States, Average Price ($), 2009-2023 10

3.6 Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016 11

3.7 Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), 2016 12

4 Overview of Key Companies in United States, Metered Dose Inhaler Devices Market 14

4.1 GlaxoSmithKline Plc 14

4.1.1 Company Overview 14

4.2 AstraZeneca Plc 14

4.2.1 Company Overview 14

4.3 Boehringer Ingelheim GmbH 14

4.3.1 Company Overview 14

4.4 Pfizer Inc 15

4.4.1 Company Overview 15

4.5 Merck & Co Inc 15

4.5.1 Company Overview 15

4.6 Sunovion Pharmaceuticals Inc 15

4.6.1 Company Overview 15

5 Financial Deals Landscape 16

5.1 Debt Offerings 16

5.1.1 Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 16

5.1.2 Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 18

5.2 Venture Financing 20

5.2.1 Propeller Health Raises USD21.5 Million in Series C Financing 20

6 Recent Developments 21

6.1 Corporate Communications 21

6.1.1 Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 21

6.1.2 Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 21

6.1.3 Mar 22, 2017: BioStable Science & Engineering Announces FDA Clearance of the HAART 300 Aortic Annuloplasty Device 21

6.2 Financial Announcements 22

6.2.1 May 31, 2017: Lamellar Biomedical Recruits First Patients into Clinical Study Assessing LAMELLEYE for Treatment of Dry Eye Disease 22

6.2.2 May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 24

6.2.3 Apr 05, 2017: InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study at the Carolinas Medical Center 26

6.2.4 Mar 29, 2017: Peer-Reviewed Clinical Study Shows ID Genomics' Bacterial Fingerprinting Technology Can Reduce Prescription Errors and Antibiotic Overuse at the Point-of-Care 26

6.2.5 Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 29

6.2.6 Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results 30

6.3 Government and Public Interest 33

6.3.1 Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 33

6.4 Other Significant Developments 33

6.4.1 Feb 21, 2017: PharmaCyte Biotech Discusses Patient Enrollment and TD2s Role in Upcoming Clinical Trial 33

6.4.2 Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration 35

6.5 Strategy And Business Planning 35

6.5.1 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America 35

7 Appendix 37

7.1 Research Methodology 38

7.1.1 Coverage 38

7.1.2 Secondary Research 38

7.1.3 Primary Research 39

7.1.4 Company Share Analysis 39

7.1.5 Distribution Share Analysis 39

7.1.6 Benchmarking 40

7.2 GlobalData Consulting 40

7.3 Contact Us 41

7.4 Disclaimer 41

1.2 List of Figures

Figure 1: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 6

Figure 2: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Figure 3: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016 8

Figure 4: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023 9

Figure 5: Metered Dose Inhaler Devices Market, United States, Company Share (%) 2016 12

1.1 List of Tables

Table 1: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 6

Table 2: Metered Dose Inhaler Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 7

Table 3: Metered Dose Inhaler Devices Market, United States, Volume (Units), Historic, 2009-2016 8

Table 4: Metered Dose Inhaler Devices Market, United States, Volume (Units), Forecast, 2016-2023 9

Table 5: Metered Dose Inhaler Devices Market, United States, Average Price ($), Historic, 2009-2016 10

Table 6: Metered Dose Inhaler Devices Market, United States, Average Price ($), Forecast, 2016-2023 10

Table 7: Metered Dose Inhaler Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 11

Table 8: Metered Dose Inhaler Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 13

Table 9: Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 16

Table 10: Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 18

Table 11: Propeller Health Raises USD21.5 Million in Series C Financing 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

GlaxoSmithKline Plc

AstraZeneca Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Merck & Co Inc

Sunovion Pharmaceuticals Inc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 4995 INR 323476
Site License
USD 9990 INR 646952
Corporate User License
USD 14985 INR 970429

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com